Three major hospital systems on Monday filed separate federal lawsuits accusing CVS Health and its affiliates of secretly conspiring to [...] …
Articles by : William Newton, Associate Editor/Senior Writer
California-based Amgen recently became the eighth pharmaceutical manufacturer to expand its 340B claims data requirements to in-house pharmacy use—and the [...] …
Please Login or Become a Paid Subscriber to View this Content
Minnesota state lawmakers failed to pass a bill that would have strengthened the state’s existing 340B contract pharmacy access law [...] …
Please Login or Become a Paid Subscriber to View this Content
A major hospital group on Wednesday asked Indiana-based drugmaker Eli Lilly to end its new 340B in-house pharmacy claims data [...] …
Please Login or Become a Paid Subscriber to View this Content
Three more decisions under the federal government’s 340B Administrative Dispute Resolution (ADR) process have sided with drugmakers—while a group of [...] …
Please Login or Become a Paid Subscriber to View this Content
Just eight days after signing a U.S. House Republican letter supporting a “robust 340B rebate model pilot,” a Mississippi congressman [...] …
Please Login or Become a Paid Subscriber to View this Content
Multiple 340B providers have recently received letters from Eli Lilly warning they could lose access to 340B pricing unless they [...] …
Please Login or Become a Paid Subscriber to View this Content
A New Orleans federal appeals court recently denied a major pharmaceutical manufacturer’s request to reconsider a ruling in favor of [...] …
Please Login or Become a Paid Subscriber to View this Content
Louisiana Attorney General Liz Murrill (R) recently told a national legal news service that her office is preparing enforcement actions [...] …
Please Login or Become a Paid Subscriber to View this Content
A Washington, D.C. federal judge recently backed the federal government’s authority to remove multiple Sagebrush clinics from the 340B program [...] …